Content » Vol 97, Issue 10

Correspondence

Cutaneous Side Effects of Single Versus Combined BRAF Inhibitors: A Comment to Erfan et al.

Rachel Anforth, Pablo Fernandez-Penas
DOI: 10.2340/00015555-2763

Abstract

Abstract is missing (Correspondence)

Significance

Related articles

Development of Cutaneous Toxicities During Selective Anti-BRAF Therapies: Preventive Role of Combination with MEK Inhibitors

Supplementary content

Comments

Not logged in! You need to login/create an account to comment on articles. Click here to login/create an account.